RhumbLine Advisers’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03M | Buy |
29,064
+922
| +3% | +$64.4K | ﹤0.01% | 1880 |
|
|
2025
Q1 | $2.07M | Sell |
28,142
-981
| -3% | -$72.1K | ﹤0.01% | 1792 |
|
|
2024
Q4 | $1.91M | Buy |
29,123
+404
| +1% | +$26.5K | ﹤0.01% | 1904 |
|
|
2024
Q3 | $2.24M | Buy |
28,719
+2,585
| +10% | +$201K | ﹤0.01% | 1845 |
|
|
2024
Q2 | $2.04M | Sell |
26,134
-609
| -2% | -$47.5K | ﹤0.01% | 1873 |
|
|
2024
Q1 | $1.81M | Buy |
26,743
+1,778
| +7% | +$120K | ﹤0.01% | 1947 |
|
|
2023
Q4 | $1.68M | Buy |
24,965
+615
| +3% | +$41.4K | ﹤0.01% | 1996 |
|
|
2023
Q3 | $1.65M | Buy |
24,350
+876
| +4% | +$59.3K | ﹤0.01% | 1951 |
|
|
2023
Q2 | $1.68M | Buy |
+23,474
| New | +$1.68M | ﹤0.01% | 2006 |
|
|
2016
Q3 | – | Sell |
-27,160
| Closed | -$820K | – | 2872 |
|
|
2016
Q2 | $820K | Sell |
27,160
-300
| -1% | -$9.06K | ﹤0.01% | 1906 |
|
|
2016
Q1 | $773K | Hold |
27,460
| – | – | ﹤0.01% | 1959 |
|
|
2015
Q4 | $932K | Buy |
27,460
+1,400
| +5% | +$47.5K | ﹤0.01% | 1857 |
|
|
2015
Q3 | $829K | Hold |
26,060
| – | – | ﹤0.01% | 1888 |
|
|
2015
Q2 | $830K | Sell |
26,060
-6,400
| -20% | -$204K | ﹤0.01% | 1991 |
|
|
2015
Q1 | $1.11M | Sell |
32,460
-2,800
| -8% | -$95.8K | ﹤0.01% | 1787 |
|
|
2014
Q4 | $1.24M | Hold |
35,260
| – | – | ﹤0.01% | 1664 |
|
|
2014
Q3 | $1.26M | Sell |
35,260
-1,000
| -3% | -$35.7K | ﹤0.01% | 1607 |
|
|
2014
Q2 | $1.35M | Buy |
36,260
+1,200
| +3% | +$44.6K | ﹤0.01% | 1640 |
|
|
2014
Q1 | $1.14M | Sell |
35,060
-200
| -0.6% | -$6.49K | ﹤0.01% | 1711 |
|
|
2013
Q4 | $1.05M | Buy |
35,260
+18,600
| +112% | +$552K | ﹤0.01% | 1779 |
|
|
2013
Q3 | $433K | Buy |
16,660
+5,800
| +53% | +$151K | ﹤0.01% | 2310 |
|
|
2013
Q2 | $257K | Buy |
+10,860
| New | +$257K | ﹤0.01% | 2776 |
|